Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-15

Clinical Trial Update: Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

This Phase 3 trial compared different methotrexate dosing regimens when taken with adalimumab in patients with early rheumatoid arthritis. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Early Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-11-15